Western medicine diagnostic systems and systems designed to test drugs for a wide range of diseases, but there is one specific test that is often overlooked: Western medicine quotes.
A study released Tuesday by the International Agency for Research on Cancer (IARC) found that Western medicine quoting costs about $20 per dose, compared with about $15 for the generic drugs.
This difference in prices could be attributed to a variety of factors, including how Western medicine has been marketed and whether the companies are actually using the same equipment, said IARC director-general Jose Calzada.
The IARC said Western medicine diagnostics are more expensive because the companies that manufacture them have a monopoly on the drugs.
But the report also found that, for the most part, Western medicine says it has more reliable tests.
“The evidence suggests that the industry is actually doing what it is claiming it is doing,” Calzad said.
The report also said Western medical diagnostics prices are generally about 20% to 30% less than generic versions of the same drugs, which are generally over $100 for the same dose.
The price difference between Western medicine and generic versions has led to concerns that some people will simply switch from the generic version to the cheaper generic version, said David Liss, an expert on medicine pricing at George Washington University.
The study did not identify any of the companies in the report that had a significant amount of market share in Western medicine, he said.
The U.S. is home to more than 300 Western medicine companies and more than 1,000 generic versions.
The U.K., France and Germany account for more than 40% of the U.N. list of the world’s most expensive medicines.
IARC recommends that governments and other health organizations limit the use of Western medicine-based medicines to prevent overuse and abuse, especially in developing countries, as well as in countries with high HIV and TB rates.
The report did not examine the impact of Western Medicine quoting prices on generic versions, which tend to have higher price tags.
A spokesman for Western Medicine, the global medical leader in the industry, declined to comment on the report.IARC does not endorse the generic versions or the companies it studies, but said it has recommended that the generic medicines used in developing and developed countries be limited to no more than three doses per person and have no more generic ingredients.